CCEP

Coca Cola Femsa (NYSE:KOF) reported record third-quarter volume, with consolidated unit case volume rising 5.3% year over year to 1.1 billion. Revenue increased 10.9% to MXN 79.7 billion, while majority net income rose 5.5% to MXN 6.2 billion.

CCEP's Southeast Asia revenues rose 9% in the first half of 2026, fueled by gains in the Philippines and Indonesia, as capacity expansion supports future growth.

CCEP's strong category growth, rising profits and healthy cash flow support its outlook, but a premium valuation and cost pressures call for caution before buying.

CCEP's 13.9% monthly rally reflects strong category growth, wider distribution and Asian expansion, but premium valuation and rising costs could limit further gains.

Coca-Cola Europacific Partners (ENXTAM:CCEP) has put $39.7 million into its Kewdale plant in Western Australia, adding a new can line that lifts capacity by over 40% and supports its long term production plans.

Is CCEP a good stock to buy? We came across a bullish thesis on Coca-Cola Europacific Partners PLC on Astute Optics – US’s Substack. The thesis was published on September 12th, when the stock was trading at $102.77, and CCEP gained 2.53% since then.

Coca-Cola boasts a 27% net margin but trades at a steep premium, while PepsiCo's diversified snacks portfolio commands a fraction of the valuation.

Coca-Cola Europacific Partners has delivered a strong multi year share price run, and that raises a straightforward question for you as an investor. Is the current market value of the stock supported by the cash it is expected to generate?

PRMB vs. CCEP: Which Stock Is the Better Value Option?

Moby summary of Coca-Cola Europacific Partners PLC's Q2 2026 earnings call

Monster energy surged 19% as zero-sugar volumes climbed, driving margin expansion.

Revenue up 6.1% and operating profit up 8.1% as the company gains market share and executes successful FIFA World Cup activations.